Limitations, agreements, and source contact

Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma · Source last updated 2016-06-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

false

limitations And Caveats

description

The study was closed prematurely because the investigator left the National Institutes of Health.

point Of Contact

email

gressr@dc10a.nci.nih.gov

organization

National Cancer Institute

phone

301-496-1791

title

Dr. Ronald Gress

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice